Introduction: Despite an early start, the provision of renal replacement therapy (RRT) in Sudan is constrained by economic factors. This report describes the ESRD population and the available renal replacement therapy (RRT) services in Sudan in 2009.
Introduction
End stage renal disease (ESRD) is a medical and social problem that constitutes a heavy burden on communities worldwide. Increasing global prevalence values of treated ESRD over the years indicate a general increase in the number of kidney failure patients as well as a gradual improvement in the access to the treatment. In 2007, more than 1,6 million patients were undergoing dialysis treatment worldwide, and another half a million patients were living with kidney transplantation [1] .
The prevalence of treated ESRD patients in the general population shows a high global variation. In 2007, ESRD prevalence was around 2,300 per million population (p.m.p.) in Japan, around 1,700 p.m.p. in the USA, and about 925 p.m.p. in the European Union. The much lower global average of 325 p.m.p. suggests that access to treatment is still limited in many countries [1] .
Intermittent peritoneal dialysis (IPD) was introduced in Sudan in 1968. In the same year, a personal set-up for home hemodialysis (HD) marked the start of HD in Sudan. The first renal unit was opened in Khartoum Teaching Hospital in 1970, where the first kidney transplant in Sudan and the second kidney transplant in the Middle East took place in 1974 [2] .
Despite this early start, the provision of renal replacement therapy (RRT) in Sudan lagged behind many neighboring countries. The reasons behind that are mainly economical. The gross domestic product (GDP) per capita in Sudan was 2,086 US$ in 2007 [3] , well below the 10,000 US$ limit that was noted by global surveys to imply economic restrictions on the prevalence of dialysis treatment [4] . Per capita total expenditure on health at average exchange 
Age and gender of ESRD patients
Prevalent HD patients had a mean age of 46 years (SD 17, range 6-95 years). Prevalent CAPD patients had a mean age of 42 years (SD 22, range 1-81 years). Prevalent kidney transplant recipients (KTR) had a mean age of 39 years (SD 13 years, range 6-80 years).
Males were commoner than females in all modalities, and children aged less than 18 years constituted a small percentage of patients (Figures 2, 3 ). This male predominance among the ESRD population is a poorly explained almost global phenomenon; with males Renal replacement therapy in Sudan constituting 68% of the dialysis population in Egypt, 56.1% in the USA , 60% in UK, and 54.5% in KSA [7] [8] [9] [10] .
Causes of kidney failure
More than 40% of surveyed patients had no identified cause for their renal impairment. This is expected as most patients present with established kidney failure. The most probable causes of kidney failure in different RRT modalities are shown (Table 1) .
Hypertension was the most commonly reported cause of ESRD (26.1%), and this is likely to be an overestimation. The diagnosis of hypertensive nephrosclerosis is difficult to ascertain even in patients with long standing hypertension. Such patients may have had secondary hypertension due to undiagnosed kidney disease.
Glomerulonephritis (GN) was the reported cause in a relatively small proportion of patients, and is probably the true underlying etiology in many of cases currently labeled as "uncertain etiology". The diagnosis of GN is rarely confirmed by renal biopsy, and often relies on the presence of renal impairment, proteinuria or active urinary sediment in the absence of other causes.
In an early description of 100 chronic renal failure patients presenting to Soba University Hospital in Sudan between 1982 and 1984, GN was reported as responsible for 38% of cases, followed by renal calculi (12%), diabetes mellitus (9%), chronic pyelonephritis (7%), sequelae of acute renal failure (5%), renal vascular disease (4%), polycystic kidney disease (3%), and obstructive uropathy not due to renal calculi (2%). In that series, the diagnosis of GN was made on the basis of small smooth kidneys seen radiologically in the intravenous urograms with the absence of other etiologic factors, and histologic confirmation was obtained for only one third of patients. Only 20% of patients were labeled to have uncertain etiology and those were patients who reached the hospital very ill and died before investigations were completed [11] .
In a previous report of 236 patients from two HD centers in Sudan, obstruction and polycystic kidney disease were reported as responsible for a similar percentage of cases (8.5% and 3% respectively), while a higher percentage was reported for GN (6.8%), a lower percentage for DM (5.9%) and a much lower percentage for hypertension (3.8%). In that series 71.2% of cases were labeled to have uncertain etiology [12] .
This variation in the reported rates of hypertensive nephrosclerosis and GN probably results from different definitions of these conditions rather than a true variation in prevalence. A similarly wide variation is noted in the reported rates of hypertension as the primary renal diagnosis of ESRD patients in UK and USA (5.8% and 24.3% respectively) [8, 9] .
The findings of the current survey are consistent with reports from other African countries, in which hypertension seems to surpass DM as a cause of ESRD. Hypertension was the reported cause of kidney failure in 21% of patients on RRT in the South African Registry, while the contribution of diabetic nephropathy was estimated to be 14-16% [13] . Hypertension accounted for 34.6% of ESRD in Black South African patients, compared to 4.3% in Whites, 13.8% in Indians, and 20.9% in people of mixed ancestry [13] .
In an early series of 115 black patients admitted to a chronic HD program in South Africa over a 4-year The total number of kidney failure patients undergoing HD was 2858 patients; 2374 (83.1%) were ESRD patients that had been maintained on HD for 3 months or more, 265 (9.3%) were ESRD patients that had been maintained on HD for less than 3 months, 28 (1%) were ARF patients, and 191 (6.7%) were patients for whom we had no data on dialysis duration.
Only 37.7% of prevalent HD patients were diagnosed to have CKD at least 3 months before dialysis initiation. The majority of patients had a functioning AV fistula (83.6%), while 7.3% had a tunneled HD catheter and 9.1% had a non-tunneled catheter. Non-tunneled catheters were most commonly placed in the jugular vein (80.9%), 18% were placed in the femoral vein and 1.1% in the subclavian vein. This complies with the NKF/KDOQI vascular access guidelines which recommend that greater than 65% of prevalent HD patients have a functional AV fistula [16] .
The prevalence of HBV infection was 6.4%, the prevalence of HCV infection was 6.5%, and 0.7% had combined HBV and HCV infection. Two earlier reports estimated the prevalence of HCV infection among a group of HD patients in Sudan to be 23.7% and 34.9% [12, 17] . However, both reports referred to one or two HD centers and do not reflect the general situation.
Due to practical constrains, adequacy measures have little practical value in our setting. Only 17% of prevalent HD patients had a documented measurement of the urea reduction ratio (URR), and only 47% achieved a URR ≥ 65%.
The target pre-dialysis blood pressure (BP) of <140/90 mmHg and the target post-dialysis BP of <130/80 mmHg were achieved in only 26.5% of patients. Only 23.1% of patients achieved the target hemoglobin of ≥ 11 g/dl. Parenteral iron was used by 69% of patients and 
Peritoneal dialysis
In 1995, there were 15 hospital beds dedicated for PD, all of them in Khartoum, and about 70 ESRD patients were maintained on IPD [2] . (Table 3) Patients were generally maintained on triple immunosuppression; 54.9% were maintained on cyclosporine, while 45.1% were maintained on tacrolimus. Target BP ≤ 130/80 mmHg was achieved only by 32.9% of patients, and target hemoglobin ≥ 11 g/dl was achieved by 81.5% of patients.
Conclusion
Access to RRT in Sudan has improved over the last two decades, but remains very low. This improvement is mostly due to the government commitment to the treatment of ESRD patients. Hypertension and DM are the most commonly reported causes of kidney failure. One third of patients live with functioning kidney grafts, and the vast majority of the remainder are maintained on HD. 
